Totals
- Total revenue
- $495,397,605
- Total expenses
- $438,196,436
- Contributions and grants received
- $0
- Grants paid
- $0
- Program service revenue
- $492,015,169
- Investment income
- $3,382,436
- Other revenue
- $0
- Total assets, end of year
- $238,533,836
- Total liabilities, end of year
- $95,429,009
- Net assets or fund balances, end of year
- $143,104,827
- Program services expenses (Part IX)
- $405,390,188
- Management and general expenses
- $32,806,248
- Fundraising expenses
- $0
- Program service expenses (Part III)
- $405,390,188
Program services were 92.5% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1a · Federated campaigns
$0
-
1b · Membership dues
$0
-
1c · Fundraising events
$0
-
1d · Related organizations
$0
-
1e · Government grants (contributions)
$0
-
1f · All other contributions, gifts and grants
$0
-
1g · Noncash contributions included above
$0
-
2a · Program service revenue: LABORATORY SERVICES
total $488,039,024 · related or exempt $488,039,024 · unrelated business $0 · excluded $0
-
2b · Program service revenue: RESEARCH & DEVELOPMENT
total $3,976,145 · related or exempt $3,976,145 · unrelated business $0 · excluded $0
-
2f · All other program service revenue
total $0 · related or exempt $0 · unrelated business $0 · excluded $0
-
3 · Investment income
total $3,220,083 · excluded $3,220,083
-
6c · Rental income or loss
real property $0 · personal property $0
-
7a · Gross sales of assets other than inventory
securities $6,137,634 · other assets $588,973
-
7b · Less cost or other basis and sales expenses
securities $5,821,030 · other assets $743,224
-
7c · Gain or loss
securities $316,604 · other assets -$154,251
-
7d · Net gain or loss
total $162,353 · excluded $162,353
-
8c · Net income from fundraising events
total $0
-
11d · All other revenue
total $0 · related or exempt $0 · unrelated business $0 · excluded $0
-
11e · Other revenue, total
$0
Functional expenses
Part IX, the statement of functional expenses.
-
4 · Benefits paid to or for members
total $0 · program services $0
-
5 · Compensation of officers, directors and key employees
total $7,193,707 · management and general $7,193,707
-
7 · Other salaries and wages
total $76,526,884 · program services $67,834,296 · management and general $8,692,588
-
9 · Other employee benefits
total $12,003,308 · program services $9,721,119 · management and general $2,282,189
-
10 · Payroll taxes
total $6,338,512 · program services $5,301,161 · management and general $1,037,351
-
11a · Fees: management
total $1,100,918 · program services $282,691 · management and general $818,227
-
11b · Fees: legal
total $452,888 · management and general $452,888
-
11c · Fees: accounting
total $145,285 · management and general $145,285
-
11f · Fees: investment management
total $117,562 · management and general $117,562
-
11g · Fees: other
total $2,963,532 · program services $779,018 · management and general $2,184,514 · fundraising $0
-
13 · Office expenses
total $1,523,818 · program services $1,377,410 · management and general $146,408
-
14 · Information technology
total $7,389,671 · program services $66,174 · management and general $7,323,497
-
16 · Occupancy
total $20,153,145 · program services $19,950,640 · management and general $202,505
-
17 · Travel
total $806,186 · program services $317,679 · management and general $488,507
-
22 · Depreciation, depletion and amortization
total $5,499,408 · program services $5,025,269 · management and general $474,139
-
23 · Insurance
total $1,107,089 · management and general $1,107,089
-
24a · Other expenses: OPERATING & TESTING SUPPLIES
total $277,290,388 · program services $277,290,388
-
24b · Other expenses: FREIGHT/SAMPLE TRANSPORTATION
total $11,954,882 · program services $11,941,648 · management and general $13,234
-
24c · Other expenses: EQUIP. LEASE, REPAIR, & MAIN
total $5,427,998 · program services $5,421,794 · management and general $6,204
-
24d · Other expenses: ALL OTHER EXPENSES
total $201,255 · program services $80,901 · management and general $120,354
-
24e · All other expenses
total $0 · program services $0 · management and general $0 · fundraising $0
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $56,219,507 · end of year $58,537,917
-
4 · Accounts receivable
beginning of year $93,336,376 · end of year $72,617,409
-
5 · Loans and receivables from officers and key people
beginning of year $0 · end of year $0
-
6 · Loans and receivables from disqualified persons
beginning of year $0 · end of year $0
-
8 · Inventories for sale or use
beginning of year $3,795,374 · end of year $3,352,159
-
9 · Prepaid expenses and deferred charges
beginning of year $2,414,938 · end of year $4,559,053
-
10a · Land, buildings and equipment: cost or other basis
$69,435,029
-
10b · Land, buildings and equipment: accumulated depreciation
$24,561,713
-
10c · Land, buildings and equipment, net
beginning of year $41,134,103 · end of year $44,873,316
-
11 · Investments: publicly traded securities
beginning of year $28,565,576 · end of year $30,092,940
-
12 · Investments: other securities
beginning of year $0
-
13 · Investments: program-related
beginning of year $0
-
15 · Other assets
beginning of year $31,760,395 · end of year $24,501,042
-
17 · Accounts payable and accrued expenses
beginning of year $67,946,211 · end of year $71,027,967
-
22 · Loans and payables to officers and key people
beginning of year $0 · end of year $0
-
25 · Other liabilities
beginning of year $31,604,045 · end of year $24,401,042
-
27 · Net assets without donor restrictions
beginning of year $157,676,013 · end of year $143,104,827
Mission and programs · 2024
Mission
TO PROVIDE EXCEPTIONAL CUSTOMIZED LABORATORY TESTING SERVICES TO SUPPORT THE HOSPITALS AND OTHER HEALTHCARE ORGANIZATIONS WITH THEIR LIFE SAVING MISSIONS.
-
DONOR TESTING BLOOD DONOR AND PLASMA TESTING SERVICES PROVIDED BY CREATIVE TESTING SOLUTIONS ("CTS") ARE ESSENTIAL TO ENSURING THE SAFETY OF THE NATION'S BLOOD AND PLASMA SUPPLY. THESE TESTING ACTIVITIES ARE ABSOLUTELY NECESSARY AND MANDATED BY THE UNITED STATES FOOD AND DRUG ADMINISTRATION ("FDA") TO PROVIDE A SAFE BLOOD PRODUCT FOR TRANSFUSION TO PATIENTS AND TO ENSURE SAFETY OF PLASMA PRODUCTS. DUE TO THE SIGNIFICANT HEALTH RISKS ASSOCIATED WITH THE USE OF HUMAN BLOOD AND BLOOD COMPONENTS, IT IS CRITICAL FOR PUBLIC SAFETY PURPOSES THAT BLOOD BE PROPERLY TESTED BEFORE BEING INTRODUCED INTO THE HEALTHCARE SYSTEM FOR USE BY PATIENTS. A SAFE BLOOD SUPPLY IS CRITICAL TO THE WELL-BEING OF THE NATION'S HEALTHCARE SYSTEM AND ITS PATIENTS. THE SIGNIFICANCE OF THE TESTING OF BLOOD FOR PUBLIC SAFETY IS EVEN MORE PRONOUNCED IN THIS AGE OF THREATS FROM PANDEMICS AND TERRORISM. CREATIVE TESTING SOLUTIONS OPERATED EIGHT DONOR TESTING LABORATORIES IN 2024. OUR FIRST ESTABLISHED LABORATORY IS IN TEMPE, ARIZONA. THE ADDITIONAL LABORATORIES ARE LOCATED IN BEDFORD, TEXAS, CHARLOTTE, NORTH CAROLINA, ST. LOUIS, MISSOURI, ST. PETERSBURG, FLORIDA, SAN MARCOS, TEXAS, AUSTIN, TEXAS, AND MEMPHIS, TENNESSEE. THESE LOCATIONS ARE STRATEGICALLY POSITIONED NEAR MAJOR AIRPORTS IN PHOENIX, DALLAS, CHARLOTTE, ST. LOUIS AND TAMPA. THE FIVE DTL LABORATORIES ARE FOOD AND DRUG ADMINISTRATION (FDA) REGISTERED FACILITIES AND HOLD CURRENT CERTIFICATIONS FOR THE CLINICAL LABORATORY IMPROVEMENT ACT (CLIA) AS WELL AS ACCREDITATION WITH THE AMERICAN ASSOCIATION OF BLOOD BANKS (AABB), THE NEW YORK STATE DEPARTMENT OF HEALTH, CALIFORNIA DEPARTMENT OF HEALTH SERVICES AND STATE OF FLORIDA AGENCY FOR HEALTH CARE ADMINISTRATION. IN ADDITION TO DONOR SPECIMEN TESTING, THE LABORATORIES PARTICIPATE IN CLINICAL EVALUATION OF REAGENTS, TEST KITS, AND EQUIPMENT. CTS PROVIDES THE HIGHEST QUALITY IN TESTING AND SERVICE. THE LABORATORIES MAINTAIN INTERNAL QUALITY CONTROL PROGRAMS AND PARTICIPATE VOLUNTARILY IN EXTERNAL QUALITY CONTROL PROGRAMS. BLOOD SPECIMENS ARE PROCESSED UTILIZING STATE OF THE ART TECHNOLOGY WITH FDA LICENSED TEST KITS AND REAGENTS. ALL LABORATORIES ARE EQUIPPED WITH MULTIPLE AND REDUNDANT INSTRUMENTS REQUIRED FOR ROUTINE PROCESSING. ADDITIONALLY, EACH FACILITY ACTS AS A BACKUP LABORATORY TO THE OTHER CTS LABS. SPECIAL TESTING OUR SPECIAL TESTING LABORATORY IN THE PHOENIX AREA PERFORMS CONFIRMATORY AND SUPPLEMENTAL TESTING OF DONOR SAMPLES AS WELL AS NON-DONATION TESTING SUCH AS DONOR RE-ENTRY, POST EXPOSURE AND DONOR FOLLOW-UP. IT ALSO PROVIDES TESTING FOR EYE BANKS, TISSUE BANKS AND CORD BLOOD CENTERS. THE SPECIAL TESTING LABORATORIES ALSO COMPLY WITH CLIA, FDA, CA, NY, MD, AND FL STATE REGULATIONS. COMPONENT QUALITY CONTROL OUR COMPONENT QUALITY CONTROL LABORATORY IN PHOENIX PROVIDES BLOOD COMPONENT QUALITY CONTROL TESTING. RESIDUAL WHITE BLOOD CELL (RWBC) COUNTS ARE PERFORMED ON LEUKOREDUCED PRODUCTS. FACTOR VIII AND FIBRINOGEN ASSAYS ARE PERFORMED ON CRYOPRECIPITATE AND PLASMA PRODUCTS. BACTERIA DETECTION IS PERFORMED ON APHERESIS PLATELETS.
Expenses $403,261,228 · Revenue $488,039,024
-
RESEARCH AND DEVELOPMENT THE CTS RESEARCH PROGRAM IS DEDICATED TO ADVANCING BLOOD SAFETY AND EVIDENCE-BASED TRANSFUSION PRACTICES THROUGH SCIENTIFIC RESEARCH. THE CTS RESEARCH PROGRAM FOCUSES ON THE DEVELOPMENT AND/OR EVALUATION OF NEW BLOOD DONOR SCREENING TECHNOLOGIES WHICH SIGNIFICANTLY IMPROVE AND PROMOTE BLOOD SAFETY IN THE AREAS OF INFECTIOUS DISEASE, IMMUNOLOGY, MOLECULAR DIAGNOSTICS, AND EPIDEMIOLOGY. ADDITIONALLY, THE CTS RESEARCH PROGRAM SERVES AS THE FOCUS FOR A MULTI-INSTITUTIONAL CONSORTIUM WHICH COLLECTS AND INTEGRATES TESTING DATA FROM A SIGNIFICANT PORTION OF THE US BLOOD SUPPLY FOR THE PURPOSE OF NATIONAL HAEMOVIGILANCE, HORIZON SCANNING FOR EMERGING INFECTIOUS DISEASES RELEVANT TO BLOOD SAFETY, AND PROVIDING CRITICAL INFORMATION FOR THE EVALUATION OF BEST PRACTICES IN TRANSFUSION MEDICINE, THE PROMOTION OF DONOR HEALTH, AND THE IMPROVEMENT OF TRANSFUSION RECIPIENT OUTCOMES.
Expenses $2,128,960 · Revenue $3,976,145
As filed on the 2024 return.
Listed in Part VII
-
NORMA SUTTON
DIRECTOR/VICE-CHAIR
- Total calculated
- $0
- Hours/week
- 1
-
Patricia ABREGO-SANTUCCI
DIRECTOR/SECRETARY
- Total calculated
- $0
- Hours/week
- 1
-
RON WAECKERLIN MD
DIRECTOR/CHAIR
- Total calculated
- $0
- Hours/week
- 1
-
ALLAN GOLDBERG
DIRECTOR (THRU 01/24)
- Total calculated
- $0
- Hours/week
- 1
-
BRIAN HAMIL
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
CHRIS HROUDA
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
CRAIG MENDELSOHN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
DAVID GREEN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
GEORGE SCHOLL
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
KATHY WALDMAN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
PAUL SULLIVAN
DIRECTOR (AS OF 04/24)
- Total calculated
- $0
- Hours/week
- 1
-
ROBERT S COLE
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
JEFFREY MODELL
CHIEF INFORMATION OFFICER
- Total calculated
- $633,408
- From this org
- $579,823
- From related orgs
- $0
- Other
- $53,585
- Hours/week
- 45
Schedule J breakdown matched by us
- Base
- $360,023
- Bonus
- $210,200
- Other
- $9,600
- Deferred
- $18,740
- Nontaxable benefits
- $34,845
- Filer's total
- $633,408
-
PHILIP WILLIAMSON PHD
CHIEF OPERATING OFFICER
- Total calculated
- $735,086
- From this org
- $683,367
- From related orgs
- $0
- Other
- $51,719
- Hours/week
- 45
Schedule J breakdown matched by us
- Base
- $428,167
- Bonus
- $245,600
- Other
- $9,600
- Deferred
- $29,067
- Nontaxable benefits
- $22,652
- Filer's total
- $735,086
-
SALLY CHOI
PRESIDENT/CEO
- Total calculated
- $1,182,073
- From this org
- $1,130,047
- From related orgs
- $0
- Other
- $52,026
- Hours/week
- 45
Schedule J breakdown matched by us
- Base
- $663,000
- Bonus
- $442,700
- Other
- $24,347
- Deferred
- $30,750
- Nontaxable benefits
- $21,276
- Filer's total
- $1,182,073
-
TANYA PERRY
CHIEF FINANCIAL OFFICER
- Total calculated
- $714,237
- From this org
- $672,374
- From related orgs
- $0
- Other
- $41,863
- Hours/week
- 45
Schedule J breakdown matched by us
- Base
- $393,178
- Bonus
- $231,200
- Other
- $47,996
- Deferred
- $27,335
- Nontaxable benefits
- $14,528
- Filer's total
- $714,237
-
Chad Westhoven
VP, QUALITY IMPROVEMENT
- Total calculated
- $382,383
- From this org
- $337,965
- From related orgs
- $0
- Other
- $44,418
- Hours/week
- 45
Schedule J breakdown matched by us
- Base
- $263,165
- Bonus
- $65,200
- Other
- $9,600
- Deferred
- $12,857
- Nontaxable benefits
- $31,561
- Filer's total
- $382,383
-
Elizabeth Davis
VP, Human Resources
- Total calculated
- $345,309
- From this org
- $295,953
- From related orgs
- $0
- Other
- $49,356
- Hours/week
- 45
Schedule J breakdown matched by us
- Base
- $230,563
- Bonus
- $55,790
- Other
- $9,600
- Deferred
- $15,200
- Nontaxable benefits
- $34,156
- Filer's total
- $345,309
-
Josh Moon
Senior Director, Automation
- Total calculated
- $263,724
- From this org
- $221,076
- From related orgs
- $0
- Other
- $42,648
- Hours/week
- 45
Schedule J breakdown matched by us
- Base
- $170,494
- Bonus
- $41,345
- Other
- $9,237
- Deferred
- $11,395
- Nontaxable benefits
- $31,253
- Filer's total
- $263,724
-
Leilani Palmer
VP, Operations
- Total calculated
- $355,102
- From this org
- $329,628
- From related orgs
- $0
- Other
- $25,474
- Hours/week
- 45
Schedule J breakdown matched by us
- Base
- $257,428
- Bonus
- $62,600
- Other
- $9,600
- Deferred
- $12,904
- Nontaxable benefits
- $12,570
- Filer's total
- $355,102
-
MARION LANTERI
VP, SCIENTIFIC AFFAIRS
- Total calculated
- $374,080
- From this org
- $354,205
- From related orgs
- $0
- Other
- $19,875
- Hours/week
- 45
Schedule J breakdown matched by us
- Base
- $276,805
- Bonus
- $67,800
- Other
- $9,600
- Deferred
- $8,263
- Nontaxable benefits
- $11,612
- Filer's total
- $374,080
-
MELINDA BRYANT
SENIOR DIRECTOR, STRATEGIC INITIATIVES
- Total calculated
- $263,410
- From this org
- $236,752
- From related orgs
- $0
- Other
- $26,658
- Hours/week
- 45
Schedule J breakdown matched by us
- Base
- $190,089
- Bonus
- $46,663
- Other
- $0
- Deferred
- $11,894
- Nontaxable benefits
- $14,764
- Filer's total
- $263,410
-
NANCY HAUBERT
VP, SOURCE PLASMA OPERATIONS
- Total calculated
- $351,569
- From this org
- $322,036
- From related orgs
- $0
- Other
- $29,533
- Hours/week
- 45
Schedule J breakdown matched by us
- Base
- $253,097
- Bonus
- $61,439
- Other
- $7,500
- Deferred
- $16,008
- Nontaxable benefits
- $13,525
- Filer's total
- $351,569
-
AUDREY LOVE
DIRECTOR, OPERATIONS II
- Total calculated
- $304,186
- From this org
- $282,286
- From related orgs
- $0
- Other
- $21,900
- Hours/week
- 45
Schedule J breakdown matched by us
- Base
- $219,836
- Bonus
- $54,950
- Other
- $7,500
- Deferred
- $6,567
- Nontaxable benefits
- $15,333
- Filer's total
- $304,186
-
JANE HIPPISLEY
DIRECTOR, OPERATIONS II
- Total calculated
- $310,290
- From this org
- $284,594
- From related orgs
- $0
- Other
- $25,696
- Hours/week
- 45
Schedule J breakdown matched by us
- Base
- $219,473
- Bonus
- $57,621
- Other
- $7,500
- Deferred
- $14,214
- Nontaxable benefits
- $11,482
- Filer's total
- $310,290
-
Lisa Crawford
Associate VP, Project Leader
- Total calculated
- $343,620
- From this org
- $305,265
- From related orgs
- $0
- Other
- $38,355
- Hours/week
- 45
Schedule J breakdown matched by us
- Base
- $235,024
- Bonus
- $70,241
- Other
- $0
- Deferred
- $14,237
- Nontaxable benefits
- $24,118
- Filer's total
- $343,620
-
Sheryl Cyrus
DIRECTOR, OPERATIONS II
- Total calculated
- $321,062
- From this org
- $280,973
- From related orgs
- $0
- Other
- $40,089
- Hours/week
- 45
Schedule J breakdown matched by us
- Base
- $218,411
- Bonus
- $55,062
- Other
- $7,500
- Deferred
- $14,381
- Nontaxable benefits
- $25,708
- Filer's total
- $321,062
-
SUBHASH PARAMESWARAN
SENIOR DIRECTOR, APPLICATIONS
- Total calculated
- $307,477
- From this org
- $281,908
- From related orgs
- $0
- Other
- $25,569
- Hours/week
- 45
Schedule J breakdown matched by us
- Base
- $226,962
- Bonus
- $54,946
- Other
- $0
- Deferred
- $14,080
- Nontaxable benefits
- $11,489
- Filer's total
- $307,477
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 1a · Housing allowance or residence for personal use
- 1b · Written policy on the line-1a expenses
- 2 · Substantiation required before reimbursing expenses
- 3 · Compensation committee
- 3 · Independent compensation consultant
- 3 · Form 990 of other organizations
- 3 · Written employment contract
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
- 4b · Supplemental nonqualified retirement plan
- 7 · Other non-fixed payments
Answered no
- 4a · Severance or change-of-control payment
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- Schedule J, Part I, Line 1a Housing allowance or residence for personal use
- JOSH MOON RECEIVED A HOUSING ALLOWANCE TO SUPPORT RELOCATING. THE BENEFIT IS TREATED AS TAXABLE COMPENSATION TO THE INDIVIDUAL.
- Schedule J, Part I, Line 4b Supplemental nonqualified retirement plan
- CERTAIN EMPLOYEES PARTICIPATE IN A SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN. THE FOLLOWING INDIVIDUALS EXPERIENCED A TAXABLE VESTING EVENT RELATED TO THIS PLAN DURING THE YEAR. THESE AMOUNTS WERE INCLUDED IN COLUMN (B)(III) AS TAXABLE WAGES. ANY PORTION THAT WAS PREVIOUSLY REPORTED ON A PRIOR 990 AS DEFERRED HAS BEEN REPORTED IN COLUMN (F). SALLY CHOI: $13,647 TANYA PERRY: $38,396
- Schedule J, Part I, Line 7 Non-fixed payments
- CREATIVE TESTING SOLUTIONS HAS AN INCENTIVE PLAN FOR MANAGEMENT AND EXECUTIVES. AWARDS UNDER THE PLAN ARE AT THE DISCRETION OF THE BOARD OF DIRECTORS. THE PLAN MEASURES PERFORMANCE AGAINST MULTIPLE METRICS, WHICH CARRY VARIOUS WEIGHTINGS, INCLUDING NET MARGIN AND CUSTOMER SERVICE. THE INCENTIVE PLAN IS DESIGNED AND APPROVED BASED ON THE RECOMMENDATIONS OF THE INDEPENDENT COMPENSATION CONSULTANT RETAINED BY THE BOARD OF DIRECTORS.
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
No itemized grants to organizations on this return.
Taxable family on this return
Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.
Disregarded entities
Part I: entities that legally are the filer and file no return of their own.
-
GENESIS GLOBAL PURCHASING ORGANIZATION
PURCHASING · AZ · income $157,528 · assets $1,214,880
Directly controlled by CTS
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 21 October 2025
- IRS schema version
- 2024v5.1
- Source object
- 202542949349302009
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.